Hymonti Dey | Biotechnology | Best Researcher Award

Dr. Hymonti Dey | Biotechnology | Best Researcher Award

Dr. Hymonti Dey, UiT The Arctic University of Norway, Norway

Dr. Hymonti Dey is an Associate Professor at UiT–The Arctic University of Norway, specializing in marine biotechnology and antimicrobial research. Originally from Bangladesh and now a Norwegian citizen, she earned her PhD in Natural Sciences in 2024, focusing on marine-derived peptide analogues against multi-resistant bacteria. With extensive research and teaching experience in microbiology, biochemistry, and marine bioactive compounds, Dr. Dey has contributed to interdisciplinary projects across Norway and abroad. Her work integrates laboratory innovation, mentorship, and collaborative science, reflecting her commitment to combating antimicrobial resistance through novel therapeutic development. 🌊🧫🔬

Publication Profile

Scopus

🎓 Education

Dr. Hymonti Dey holds a PhD in Natural Sciences (Marine Biotechnology) from UiT–The Arctic University of Norway (2019–2024), where she explored antimicrobial peptides of marine origin. She earned her MSc in Medical Biology from the University of Bergen (2014–2016), following an MSc and BSc in Biochemistry and Molecular Biology from the University of Dhaka (2005–2010). Her academic journey has spanned prestigious institutions in Bangladesh and Norway, equipping her with interdisciplinary expertise in biochemistry, molecular biology, and microbiology. This diverse academic background supports her advanced research in marine bioactive compounds and bacterial resistance. 📘🧬🧪

💼 Experience

Dr. Dey began her research career at icddr,b in Bangladesh, advancing from Senior Research Assistant to Research Officer in tuberculosis diagnostics and immunoassays. She continued as a Research Trainee at the University of Oslo, focusing on biofilm analysis and qPCR, before joining UiT as a PhD researcher. Her doctoral work centered on marine-derived antimicrobials and biosensor applications. Following her PhD, she worked as a Scientific Assistant and now serves as an Associate Professor at UiT, where she teaches biotechnology and microbiology, supervises theses, and leads lab-based instruction. She has also conducted external research stays in Oslo. 🧫📚👩‍🏫

🏆 Awards & Honors

Dr. Hymonti Dey has been recognized through prestigious roles and research opportunities, including her appointment as Associate Professor shortly after completing her PhD—a testament to her academic excellence and research contributions. She was involved in competitive UiT-funded projects such as LEADScAMR and AntifoMar and participated in international collaborations that expanded her expertise in antimicrobial innovation. Her supervision of Master’s theses and consistent teaching roles also reflect recognition by academic peers. With a Class B driving license, she maintains professional flexibility for collaborative and field research. 🥇📜🧠

🔬 Research Focus

Dr. Dey’s research focuses on the development and characterization of marine-derived antimicrobial peptides and peptidomimetics targeting multi-drug resistant bacteria. Her work spans bioactivity assays, antibiofilm testing, mode of action studies using bacterial biosensors, and engineering whole-cell biosensors. Key projects include LEADScAMR, AntifoMar, and biosensor development at UiT, which integrate microbiology, biotechnology, and natural product chemistry. Her multidisciplinary approach aims to discover and optimize novel scaffolds for combating antibiotic resistance. Through microscopy, PCR, MALDI-TOF, and flow cytometry, she advances bioanalytical strategies in therapeutic innovation. 🌐🧬🧫💡

Publication Top Notes

  • 2022: “Synthesis and Antimicrobial Activity of Short Analogues of the Marine Antimicrobial Peptide Turgencin A” – Int J Mol Sci

  • 2023: “Outer Membrane Integrity-Dependent Fluorescence of the Japanese Eel UnaG Protein in Live Escherichia coli Cells” – Biosensors

  • 2023: “Investigation of Tetrasubstituted Heterocycles Reveals Hydantoins as a Promising Scaffold for Development of Novel Antimicrobials” – Eur J Med Chem

  • 2022: “A Concise SAR-Analysis of Antimicrobial Cationic Amphipathic Barbiturates for an Improved Activity-Toxicity Profile” – Eur J Med Chem

  • 2020: “NarAB Is an ABC-Type Transporter That Confers Resistance to Polyether Ionophores” – Front Microbiol

  • Under Review: “Antimicrobial Activity of Short Analogues of the Marine Peptide EeCentrocin 1” – Journal of Peptide Science

  • 2015: “Longitudinal Immune Profiles in Type 1 Leprosy Reactions in Bangladesh, Brazil, Ethiopia and Nepal” – BMC Infect Dis

  • 2013: “Feasibility of Using Non-Respiratory Specimens for Diagnosis of Child Tuberculosis” – Int J Tuberc Lung DisMDPIPubMedBioMed Central

Dr. Miguel Virseda-Chamorro | Medicine | Best Paper Award

Dr. Miguel Virseda-Chamorro | Medicine | Best Paper Award 

Dr. Miguel Virseda-Chamorro, FEA, Hospital Nacional de parapléjicos, Spain.

Miguel Vírseda Chamorro is a seasoned medical professional with expertise in urology. Born in Zaragoza, Spain, in 1956, Miguel has dedicated over three decades to research, education, and clinical practice in the field of urology. Throughout his career, he has specialized in the treatment of lower urinary tract disorders, urological dysfunctions, and has made significant contributions through his research in the field of neurourology and urodynamics.

Profile

scopus

orcid

Strengths for the Award

  1. Extensive Research Background: Chamorro has participated in numerous clinical trials and published papers over decades, specifically focusing on urology and related areas such as spinal cord injuries and urinary tract infections.
  2. Recognized Expertise: His work has been acknowledged with multiple awards and recognitions, including best doctoral thesis and research prizes in the field of urology.
  3. International Contributions: Chamorro’s involvement in various international scientific meetings (e.g., International Continence Society) and peer-reviewed publications highlights his contributions to global scientific dialogue.
  4. Educational Contributions: Directing doctoral theses and contributing to advanced academic courses in urology positions him as a thought leader in his field.

Areas for Improvement

  • Interdisciplinary Reach: While his work is specialized in urology, expanding to interdisciplinary research that bridges other medical fields or innovations in treatment techniques might add depth to his paper’s impact.

Novel Research: Chamorro has done extensive work on known conditions, but for a “Best Paper Award,” research on cutting-edge topics, such as emerging technologies or new medical approaches, could further elevate his candidacy.

Education 🎓

Miguel Vírseda Chamorro has a diverse and accomplished educational background. He began his academic journey with a degree in Industrial Engineering at the Universidad Politécnica de Las Palmas in 1973. He later obtained his Licenciatura in Medicine and Surgery from the University of Valencia in 1981, followed by a degree in Law from the National University of Distance Education (UNED) in 2011. He specialized in Urology at Hospital Gómez Ulla in 1990 and pursued further studies, earning a Master’s in Design and Statistics in Health Sciences from the Autonomous University of Barcelona in 2001. His Doctoral Thesis, completed in 1992, received the prestigious Cum Laude distinction.

Experience 💼

Miguel’s career spans over three decades, including extensive experience in urological surgery, teaching, and research. He became a Fellow of the European Board of Urology in 1992 and has been an accredited Professor since 2005, working with several medical institutions. His medical experience is also enriched by his work as Director of Radiodiagnostic Installations, certified by the Spanish Nuclear Safety Council in 2007. He has served in various clinical roles, significantly contributing to both the practice and teaching of urology and urodynamics.

Research Interests 🔬

Miguel’s primary research interests lie in neurourology, urodynamics, and the impact of pelvic dysfunction on urinary systems. His research has focused on urinary tract dysfunctions, neurogenic detrusor overactivity, and the application of botulinum toxin in urological conditions. He is particularly interested in exploring diagnostic techniques, treatment methods, and prognostic factors for patients with spinal cord injuries and other neurological disorders affecting urological health.

Awards and Recognition 🏆

Miguel has been recognized with numerous awards for his outstanding work in the field of urology. In 1992, his doctoral thesis was awarded the Best Thesis Prize by the Spanish Association of Urology. He has received multiple accolades, including the Enrique Pérez Castro Third Prize for his research on urodynamic models in 1998, and the distinction for “Best Urological Functional Case” at the National Urology Congress in 2011. His latest recognition includes the ACACI Research Award for his study on chronic pelvic pain syndrome in women.

Publications 📚

Miguel has published extensively in renowned medical journals, contributing significantly to the field of urology. Below are some of his recent publications:

    1. Abdominal strength in voiding cystometry: a risk factor for recurrent urinary tract infections in women. Int Urogynecol J, 2015. Cited by: 45
    2. Risk factors of urethral diverticula in male patients with spinal cord injury. Spinal Cord, 2015. Cited by: 23
    3. Post Pelvic Radiotherapy Affectation of the Lower Urinary Tract Peripheral Innervation in Men. Urol Int, 2017. Cited by: 18
    4. Influence of bladder lithiasis on lower urinary tract dynamics in patients with spinal cord injury. Spinal Cord, 2017. Cited by: 30
    5. Clinical and urodynamic risk factors for recurrent urinary tract infections in multiple sclerosis. Multiple Sclerosis Journal, 2018. Cited by: 35

Conclusion

Chamorro’s achievements in urology and academic research, coupled with his global recognition, make him a strong contender for the award. Expanding his research focus and emphasizing innovation in his recent work would further bolster his potential for winning.